ABSTRACT Acinetobacter baumannii is an important nosocomial pathogen. The objective of this study was to determine the proportion of A. baumannii infections due to patient-to-patient transmission by analyzing the molecular epidemiology of patients who acquired A. baumannii, using perianal surveillance cultures in a large 2-year intensive care unit (ICU) population. The design was a prospective cohort study. Patients who were admitted to the medical and surgical intensive care units at the University of Maryland Medical Center from 2011 to 2013 underwent admission, weekly, and discharge perianal culture collection. Using multilocus sequence typing (MLST) with subsequent pulsed-field gel electrophoresis (PFGE) for increased discrimination, combined with hospital overlap, the number of patients that acquired A. baumannii due to patient-to-patient transmission was determined. Our cohort consisted of 3,452 patients. In total, 196 cohort patients were colonized with A. baumannii; 130 patients were positive at ICU admission, and 66 patients acquired A. baumannii during their stay. Among the 196 A. baumannii patient isolates, there were 91 unique MLST types. Among the 66 patients who acquired A. baumannii, 31 (50%) were considered genetically related by MLST and/or PFGE type, and 11 (17%) were considered patient-to-patient transmission by genetic relatedness and overlapping hospital stay. Our data show that, of those cases of A. baumannii acquisition, at least 17% were cases of patient-to-patient transmission.
endogenous antibiotic selective pressure is not fully understood. Most previous studies that attempted to measure the fraction of Acinetobacter spp. acquisitions due to patient-to-patient transmission have been limited and involved the use of clinical cultures only (8, 9) .
The objective of this study was to analyze the molecular epidemiology of patientacquired A. baumannii from perianal surveillance cultures in a large intensive care unit (ICU) population. We aimed to quantify the amount of patient-to-patient transmission versus endogenous acquisition of patients' A. baumannii among our large cohort of ICU patients. Understanding the causal mechanisms of acquisition of A. baumannii will aid in providing the appropriate care of patients to prevent and control the dissemination of A. baumannii in the health care setting.
RESULTS
Our cohort included 3,452 patients who underwent two cultures, one on admission and a subsequent one at discharge or, if a discharge culture was not available, a weekly culture. Compliance with obtaining admission perianal surveillance cultures was 92%, and discharge or weekly culture compliance was 75%.
In total, 196 patients (5.6%) were colonized with A. baumannii. Demographics for the 196 colonized patients were as follows: mean age, 56 years; 113 (57.7%) male; and mean Charlson score, 3.37. A total of 130 patients (3.8%) were colonized on admission to the ICU and were defined as admission-positive patients. A total of 66 patients (1.9%) had an admission culture negative for A. baumannii and a subsequent weekly or discharge culture positive for A. baumannii and were defined as patients who acquired A. baumannii. A total of 103 isolates (53%) were multidrug resistant (MDR), 78 (40%) were extensively drug resistant (XDR), and there were no pandrug-resistant (PDR) A. baumannii isolates.
The molecular typing experiments discriminated the 196 A. baumannii isolates into 91 MLST types (See Table S1 ). The four largest MLST types, consisting of 78 isolates, were further characterized into 60 unique PFGE types. A total of 25 isolates were unique and unable to be typed by MLST. Isolates from 41 patients (62%) out of the 66 that acquired A. baumannii were classified by MLST to have a similar genetic profile as another patient's isolate. A total of 31 of the 66 (50%) isolates from patients that acquired A. baumannii were classified by MLST and/or PFGE to have a similar genetic profile as another patient's isolate. Of these, 11 (17%) had a similar molecular profile, in addition to a hospital stay within 30 days of the other patient, and were therefore classified as patient-to-patient transmission. A total of 10 out of the 11 patient-topatient isolates were MDR or XDR.
DISCUSSION
In this study, we analyzed the molecular epidemiology of patients who acquired A. baumannii by using perianal surveillance cultures from a large cohort of intensive care unit patients. We found that of the 66 patients who acquired A. baumannii, 17% met our definition of patient-to-patient transmission, which included a genetically similar isolate based on PFGE and MLST with an overlapping hospital stay. Fifty percent had a genetically similar isolate based on criteria of PFGE and/or MLST alone. We found that 53% of the A. baumannii isolates were MDR and 40% were XDR, consistent with the literature (10) .
A. baumannii has been previously demonstrated to spread through patient-topatient transmission. Patients colonized with A. baumannii have been shown to frequently contaminate their environment (11, 12) . Healthcare workers taking care of patients with antibiotic-resistant A. baumannii acquire it on their gloves and gowns 38% of the time (13). This transient acquisition could then lead to subsequent patient transmission if meticulous doffing of personal protective equipment and hand hygiene are not performed. Patients admitted to rooms where previous occupants had A. baumannii are also at increased risk of acquiring A. baumannii (14) . Outbreaks due to A. baumannii are common and, in many cases, the spread of genetically related strains has been demonstrated (3). In fact, A. baumannii transmission has primarily been studied in the outbreak setting. However, numerous other studies have identified data suggesting that A. baumannii endemicity arises due to significant patient-to-patient transmission (1, 3, 6) .
A number of studies have investigated the transmission of A. baumannii using molecular epidemiological techniques, including PFGE, MLST, and whole-genome sequencing (WGS). A study in Thailand performed PFGE on 197 A. baumannii clinical isolates and found nine PFGE groups. They reported that spatiotemporal analysis identified 20 clusters of single PFGE group infections and concluded that a large amount of patient-to-patient transmission occurred both within and between hospital wards (15) . Similarly, a study in Israel performed PFGE on 96 MDR A. baumannii clinical isolates and found 18 different PFGE clones; using epidemiologic data, they determined that "transmission opportunities" were present in a significantly greater number of cases involving patients with the same clone versus those with different clones. They also concluded that patient-to-patient transmission accounted for most of the cases (9) . A study analyzing an outbreak of A. baumannii in a unit used MLST, PFGE, and WGS and demonstrated patient-to-patient transmission (16) . Finally, Doan et al. sought to characterize the transmission dynamics of A. baumannii using mathematical modeling. Among three hospitals with various incidences of A. baumannii infection, they found that patient-to-patient transmission accounted for 96 to 98% of isolates in the hospitals with a high incidence, while sporadic acquisition was more common in the hospital with a lower incidence (17) . A major difference between these studies and ours is that these studies focused on clinical culture positivity and we address colonization only. As well, the majority of these studies were done in the outbreak setting (9, 16) . In addition, although these studies all conclude that patient-to-patient transmission accounts for most of the cases, most of these studies did not use genetic and epidemiologic criteria to specifically quantify the fraction of acquisitions that are acquired from patient-topatient, but solely used molecular epidemiological techniques. In our study, we found that 17% of patients who acquired A. baumannii met our criteria for patient-to-patient transmission (18) , much less than the "majority" reported in other studies; however, using only molecular epidemiological definition of PFGE and MLST, we found a 50% transmission rate. We do not know why this difference exists. It may represent A. baumannii that persisted in the environment for longer periods of time or on contaminated equipment (19, 20) or may represent molecular epidemiological techniques that do not have enough discrimination.
Our group, using the same type of ICU cohort and similar molecular methodology to quantify the amount of acquisition due to patient-to-patient transmission of nonAcinetobacter spp., has found variability in transmission based on organism type. For extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli, 13% of cases in which this pathogen was acquired in the ICU setting were due to patient-to-patient transmission (21) . For imipenem-resistant Pseudomonas aeruginosa, 31% of acquisitions were due to patient-to-patient transmission (22) . For ESBL-producing Klebsiella organisms, 52% of acquisitions were due to patient-to-patient transmission (23) .
This study has several limitations. First, this analysis was performed at a single center and may not reflect the transmission dynamics in other settings. In addition, we did not perform WGS. Recent studies have shown higher discrimination with WGS than with other methods (24) . Since WGS has better discrimination, we advance that, had we used this method, a different number of A. baumannii isolates would have been determined to be due to patient-to-patient transmission. We also did not perform PFGE on all isolates. However, this would have resulted in at most 4 acquisitions being misclassified as patient-to-patient transmission if the PFGE results had showed differences that were not revealed by MLST. As well, we did not analyze respiratory samples. A. baumannii is known to have the respiratory tract as a primary site of colonization. Different results may have arisen if we also included clinical cultures in the analysis, but we did not do this because clinical culture results are affected by culturing frequency, which is not standardized and is affected by clinical indications.
In conclusion, our study suggests that patient-to-patient transmission is an important cause of the acquisition of A. baumannii colonization. However, its importance seems to be less than that of the amount of patient-to-patient transmission of A. baumannii in the outbreak setting. Future studies are needed using surveillance cultures and in nonoutbreak settings to see if our results are generalizable. Our data support the notion that multifaceted interventions combining antibiotic stewardship and infection control are needed to control the continued emergence of A. baumannii.
MATERIALS AND METHODS
Study design and patient population. This study was approved by the institutional review board (IRB) of the University of Maryland, Baltimore, and was conducted at the University of Maryland Medical Center (UMMC), a tertiary care hospital with an 816-bed capacity located in Baltimore, MD. This prospective cohort included adult patients in the medical ICU (MICU) and surgical ICU (SICU) between 1 May 2011 and 1 May 2013. The MICU is a 29-bed unit that provides care to adult patients who have acute or potentially life-threatening medical conditions, including hematologic and other malignancies. The SICU is a 24-bed unit that admits adult patients postsurgery and with surgical complications. The primary outcome was A. baumannii colonization as defined by presence of A. baumannii on ICU perianal surveillance swab.
During the study period, patients in the MICU and SICU underwent admission, weekly, and discharge perianal surveillance cultures. The culturing technique involved swabbing the perianal area in a circular motion. Samples for cultures were obtained as part of an ongoing infection prevention vancomycinresistant enterococcus active surveillance program. Swabs were plated to VRE Chromagar and frozen at Ϫ80°C in tryptic soy broth with 15% glycerol.
We defined admission-positive patients as patients who had admission cultures positive for A. baumannii. We defined acquisition-positive patients as patients who had admission cultures negative for A. baumannii and had either a subsequent weekly or discharge surveillance culture that was positive for A. baumannii.
Microbiological methods. Perianal swabs were placed in brain heart infusion broth (Becton, Dickinson, Sparks, MD) overnight at 37°C. The next day, 50 l were plated to Acinetobacter Chromagar (Northeast Laboratory Services, Winslow, ME) and incubated overnight. Red colonies were plated on tryptic soy agar with 5% sheep blood (Becton, Dickinson, Sparks, MD) for bacterial identification using a Vitek 2 instrument (bioMérieux, Durham, NC). Susceptibilities were performed following CLSI guidelines (25) . We defined MDR, XDR, and PDR A. baumannii using Mariorakos et al. (26) .
Multilocus sequence type. We performed MLST using the Oxford scheme for the Acinetobacter baumannii complex (http://pubmlst.org/abaumannii/). PCR primers were chosen from previous studies and were designed for the amplification of the following 7 genes: gltA (encoding citrate synthase), gyrB (DNA gyrase subunit B), gdhB (glucose dehydrogenase B), recA (homologous recombination factor), cpn60 (60-kDa chaperonin), gpi (glucose-6-phosphate isomerase), and rpoD (RNA polymerase sigma factor).
Isolates were cultured overnight on blood agar at 37°C. Following incubation, a loopful from a colony was suspended in 100 l of molecular grade water (Fisher Scientific, Hampton, NH) and boiled for 15 min. PCR amplifications were performed on a Bio-Rad iCycler system (Bio-Rad, Hercules, CA) under the following conditions: 35 cycles (denaturation at 94°C for 30 s, annealing at 55°C for 45 s, and extension at 72°C for 1 min) preceded by a 2-min denaturation at 94°C and followed by a 5-min extension at 72°C. PCR products were purified from the reaction mixture using the QIAquick PCR purification kit (Qiagen, Hilden, Germany). Sequencing of the internal fragments of the selected housekeeping genes was performed by the University of Maryland School of Medicine Center for Innovative Biomedical Resources (Genomics facility)-Baltimore, Maryland. Sequence data were aligned and edited by using the Sequencher program (version 5.4; Gene Codes Corporation, Ann Arbor, MI).
Molecular methods and definition of patient-to-patient transmission. PFGE was performed on a subset of isolates in large groups with identical MLST types, as previously described (27, 28 ; https:// www.cdc.gov/pulsenet/pathogens/index.html) with the following modifications. The following subset algorithm was performed for cost saving reasons, so that fewer samples had PFGE performed. The four largest groups, each with a total of Ն15 isolates, had PFGE performed. A total of 75 isolates had PFGE performed. Only 4 patient acquisitions did not have PFGE performed on all isolates within a MLST type. All isolates were digested with ApaI, and the resulting fragments were separated by electrophoresis in 1% agarose gels with the CHEF-DR II (Bio-Rad Laboratories, Hercules, CA) for 18.5 h, with switch times ranging from 7 to 20 s in Tris-borate EDTA (TBE) buffer containing 50 M thiourea. Photographic images of the gels were saved digitally with the Gel Doc EQ (Bio-Rad Laboratories, Hercules, CA) and saved as Tagged Image File Format (TIFF) files for gel analysis with GelCompar II Software (Applied Maths, Austin, TX). The band patterns were compared by means of the Dice coefficient, using the unweighted pair-group method to determine band similarity using the criteria established by Tenover et al. to define the pulsed-field type clusters (29) . PFGE types were defined as isolates that are 100% identical (PFGE type 1, 2, or 3) and genetic relatedness (for example, A, B, C) was determined by isolates that had 80% or greater similarity. For patients who acquired an A. baumannii isolate, we also assessed for overlap in hospital stay. Using criteria described by Greenblatt et al., we defined patient-to-patient transmission as genetically related isolates from subjects with dates of hospitalization separated by no more than 30 days (18) .
Statistical analysis. Statistical comparisons were performed by using the chi-square and Fisher's exact tests. The significance level was set at P Ͻ 0.05. Statistical analysis was performed with SAS version 9.1 (SAS Institute, Cary, NC).
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